Old National Bancorp’s Immix Biopharma IMMX Stock Holding History

Old National Bancorp’s Portfolio IMMX Stock Details IMMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-10,000	Closed	-$14.9K	–	672
2024 Q3	$14.9K	Hold	10,000	–	–	﹤0.01%	646
2024 Q2	$19.8K	Hold	10,000	–	–	﹤0.01%	622
2024 Q1	$30.7K	Hold	10,000	–	–	﹤0.01%	626
2023 Q4	$69.2K	Buy	+10,000	New	+$45.3K	﹤0.01%	635

Other funds holding IMMX

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

CCC

Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TAM

Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Old National Bancorp's IMMX Position: Q4 2024 in Review

Old National Bancorp sold out of Immix Biopharma (IMMX) in Q4 2024, closing a stake of 10,000 shares — an estimated $14.9K sold.

Old National Bancorp first reported a position in IMMX in Q4 2023 and held it in 4 quarters. The position peaked at $69.2K in Q4 2023. 23 funds tracked by Wall St. Rank hold IMMX as of Q4 2024.

Old National Bancorp reported no remaining Immix Biopharma position as of Q4 2024 after selling out during the quarter.
Old National Bancorp sold 10,000 Immix Biopharma shares in Q4 2024, an estimated $14.9K.
Old National Bancorp first reported a position in Immix Biopharma in Q4 2023 and held it in 4 quarters.
Old National Bancorp's Immix Biopharma position peaked at $69.2K in Q4 2023.
23 funds tracked by Wall St. Rank held Immix Biopharma as of Q4 2024.

Based on Old National Bancorp's 13F filing for Q4 2024, filed 23 Jan 2025.